This year’s GCR Live Pharmaceuticals conference will dissect antitrust hot topics affecting the pharma industry in the US and beyond. On tap is a top-level panel discussion of the latest antitrust enforcement actions intended curtail "killer" pipeline acquisitions in order to protect consumers and competition between drugmakers. It will also delve into drug pricing practices, asking whether legislative remedies are enough to address pricing ills in the market.
The conference will close with an update on the current state of antitrust litigation affecting the industry. Andrea Murino will be speaking on the "Killer Acquisitions in the Pharmaceutical Sector" panel.
For more information, please visit the event website.